Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARMADA-AD Atopic Dermatitis Disease Registry
jRCT1030260092Recruiting
- Sponsor
- Sanofi
- Start
- Apr 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cyclosporine, azathioprine, methotrexate and mycophenolate mofetil in atopic dermatitis (AD), sponsored by Sanofi. Primary endpoints: Utilization patterns of systemic therapy for atopic dermatitis and Clinical outcomes measured by ClinROs and PROs. Started Apr 2026; status: recruiting.
02
Drugs
cyclosporineazathioprinemethotrexatemycophenolate mofetil
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT1030260092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030260092.